CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 16 No. 5
Pages: 1  2  
Next
The Sonis/Fey Article Reviewed 

Oral Complications of Cancer Therapy

By

Scott Okuno, MD
Consultant, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
Charles Loprinzi, MD

Chair, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota

| May 1, 2002

Drs. Sonis and Fey provide a nice description of the problems associated with oral mucositis, information available regarding its etiology, and the cost generated by its treatment.

In their discussion of oral mucositis, the authors present a long list of theoretical antidotes, many of which offer glimpses of hope that they may be effective. None of these potential therapies, with one exception, has actually been proven to be helpful in clinical practice. The list of possible antidotes includes sucralfate(Drug information on sucralfate), allopurinol(Drug information on allopurinol), glutamine, pentoxifylline(Drug information on pentoxifylline), vitamin E, beta-carotene, azelastine(Drug information on azelastine) (Astelin), amifostine(Drug information on amifostine) (Ethyol), misoprostol(Drug information on misoprostol) (Cytotec), benzydamine(Drug information on benzydamine) (Tantum), immunoglobulin, chlorhexidine, iodine(Drug information on iodine)" target="_blank">povidone iodine(Drug information on povidone iodine), nonabsorbable antibiotic lozenges, keratinocyte growth factor, interleukin (IL)-11, granulocyte colony-stimulating factor (G-CSF [Neupogen]), and oral cryotherapy.

Oral Cryotherapy

The only one of these approaches with proven efficacy is oral cryotherapy (noting that new data regarding keratinocyte growth factor may soon add this to the "proven efficacy" list). Drs. Sonis and Fey state that "cryotherapy with ice chips seems to be marginally beneficial in patients being treated with [fluorouracil (5-FU)]." They reference one trial that compared 30 minutes of cryotherapy with 60 minutes of cryotherapy, as opposed to referencing one of the two controlled clinical trials that established the benefit of this therapy. We would like to more definitively state that oral cryotherapy is substantially proven to be efficacious in the prevention of mucositis related to bolus-dose 5-FU chemotherapy.

The rationale behind this treatment approach is based on the fact that 5-FU has a short serum half-life (10 to 15 minutes). It was hypothesized that putting ice chips in the mouth 5 minutes before administering a 5-FU bolus injection and continuing to do so for 30 minutes would cool the oral cavity and lead to vasoconstriction. The vasoconstriction would hypothetically allow less 5-FU to get to the oral mucosa, thereby hopefully attenuating 5-FU-induced mucositis.

This hypothesis was tested in a late-1980s clinical trial, in which 95 patients were randomly assigned to either receive oral cryotherapy or not (the latter serving as a control group). All patients were receiving bolus 5-day intravenous 5-FU-based chemotherapy, and none had received prior chemotherapy. Patients randomized to oral cryotherapy placed crushed ice chips in their mouths 5 minutes prior to each dose of 5-FU. They were instructed to continuously swish the ice around in their oral cavities and replenish it before the previous mouthful had completely melted, for a total of 30 minutes. As evaluated by standard physician grading and patient questionnaires, mucositis was reduced by approximately 50% in the group receiving oral cryotherapy, compared to the control arm.[1]

Another group independently conducted a trial to confirm or refute these findings. This group randomly allocated 84 patients, being treated with 5-FU-containing regimens, to either oral cryotherapy or a control arm.[2] These authors reported virtually identical findings, with approximately a 50% reduction in mucositis in the group receiving the oral cryotherapy.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy